Homer 2 antagonizes protein degradation in slow-twitch skeletal muscles

Elena Bortoloso1, Aram Megighian, Sandra Furlan

  • 1Dipartimento di Scienze Biomediche, Università degli Studi di Padova, viale G. Colombo 3, 35121 Padova, Italy.

Insights

Homer 2 protein levels decrease during skeletal muscle atrophy. Restoring Homer 2 helps maintain muscle mass and reduce protein breakdown by downregulating atrophy-related genes.

Area of Science:

  • Molecular Biology
  • Skeletal Muscle Physiology
  • Protein Isoforms

Background:

  • Homer proteins comprise a diverse family with multiple isoforms.
  • Homer 1b/c and Homer 2a/b isoforms are present in skeletal muscle.
  • Homer 2a/b is specifically associated with slow-twitch muscle fibers.

Purpose of the Study:

  • Investigate Homer isoform distribution in fast- and slow-twitch skeletal muscles.
  • Examine changes in Homer isoform composition during muscle atrophy models (denervation and disuse).
  • Determine the role of Homer 2 in regulating muscle mass and proteolysis during atrophy.

Main Methods:

  • Analysis of Homer 1b/c and 2a/b isoforms in rat and mouse skeletal muscles.
  • Experimental induction of atrophy via denervation and hindlimb suspension in rats.
  • In vivo transfection to restore Homer 2 levels in denervated soleus muscle.
  • Assessment of muscle mass, fiber size, ubiquitination, and gene expression (MuRF1, Atrogin, Myogenin).

Main Results:

  • Homer 2a/b is characteristic of slow-twitch muscle and significantly decreases during denervation and disuse atrophy.
  • Downregulation of Homer 2a/b mRNA and protein occurs early in the atrophic process.
  • Restoring Homer 2 in denervated soleus partially rescued muscle mass and reduced ubiquitination.
  • Exogenous Homer 2 downregulated MuRF1, Atrogin, and Myogenin, counteracting atrophy-associated gene upregulation.

Conclusions:

  • Homer 2 downregulation is an early indicator of skeletal muscle atrophy.
  • Homer 2 plays a crucial role in controlling ubiquitination and proteolysis through transcriptional regulation of key atrophy genes.
  • Homer proteins, particularly Homer 2, are vital for skeletal muscle plasticity and maintaining trophic homeostasis in slow-twitch muscles.

Related Concept Videos

Relaxation of Skeletal Muscles01:29

Relaxation of Skeletal Muscles

The period of muscle contraction primarily influences the duration of stimulation at the neuromuscular junction (NMJ), the presence of free calcium ions in the sarcoplasm, and the availability of energy or ATP to support contractions.
When an action potential reaches the axon terminal, it depolarizes the membrane and opens voltage-gated sodium channels. Sodium ions enter the cell, further depolarizing the presynaptic membrane. This depolarization causes voltage-gated calcium channels to open.
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin01:26

Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin

Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
Cross-bridge Cycle01:26

Cross-bridge Cycle

As muscle contracts, the overlap between the thin and thick filaments increases, decreasing the length of the sarcomere—the contractile unit of the muscle—using energy in the form of ATP. At the molecular level, this is a cyclic, multistep process that involves binding and hydrolysis of ATP, and movement of actin by myosin.
Skeletal Muscle Relaxants: Adverse Effects01:21

Skeletal Muscle Relaxants: Adverse Effects

Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
Skeletal Muscle Relaxants: Therapeutic Uses01:31

Skeletal Muscle Relaxants: Therapeutic Uses

Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx as...
Classification of Skeletal Muscle Relaxants01:28

Classification of Skeletal Muscle Relaxants

Skeletal muscle relaxants are a group of drugs that can reduce muscle stiffness and induce temporary paralysis to relieve pain. These agents can act centrally to reduce muscle tone or spasms in painful conditions such as multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), or spinal injuries; they are called antispasmodics or spasmolytics.
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...